We are excited to present Cadus Corp. (OTC: KDUS).

You must become a subscriber to view this report.

Recent News from (OTC: KDUS)

NEW YORK , May 17, 2018 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating Cadus Corporation ("Cadus" or the "Company") (Other O...

This article is part of a series that provides an ongoing analysis of the changes made to Carl Icahn’s 13F portfolio on a quarterly basis. It is based on Icahn’s regulatory 13F Form filed on 02/14/2018. Please visit our Tracking Carl Icahn’s Portfolio series to get an ...

NEW YORK, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Cadus Corporation (OTCMKTS:KDUS) (the “Company” or “Cadus”) today announced that it had entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Starfire Holding Corporation (“Star...

This article is part of a series that provides an ongoing analysis of the changes made to Carl Icahn’s 13F portfolio on a quarterly basis. It is based on Icahn’s regulatory 13F Form filed on 11/14/2017. Please visit our Tracking Carl Icahn’s Portfolio series to get an ...

NEW YORK, NY --(Marketwired - October 27, 2017) - Cadus Corporation (OTCBB: KDUS) announced that its Board of Directors has formed a special committee of independent directors to consider an offer by Barberry Corp. and High River Limited Partnership, which collectively beneficially own...

Note: At the time I was writing this and purchasing additional shares, the stock was trading at $1.2 for a spread of 8.3%. At the time of the publication of this article, the stock has traded up to $1.23, compressing the spread to 5.7%. Earlier this year I wrote about KDUS. In the artic...

NEW YORK, NY--(Marketwired - Dec 9, 2015) - Cadus Corporation ( OTCBB : KDUS ) announced today that it has established its new corporate web-site, CadusCorp.com. The website currently permits the visitor to view the location of certain of the company's properties in Miami-Dade ...

Welcome to this week's edition of Biotech Weekly! While biotech has had a very tumultuous last few weeks, the indexes had a good week with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB ) rising 4.0% and the S&P Biotech ETF (NYSEARCA: XBI ) gaining 5.4% bringing the IBB to a 16.3% YTD...

The Research: All source information contained in this email is from the public sources mentioned below.

Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in KDUS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of KDUS and does not buy, sell, or trade any shares of KDUS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/